DISPOSITIFS DE CYTOCENTRIFUGATION

European patent · EP4055361 · In force

Register entry

Publication number
EP4055361
Application number
EP20816279
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Nov 6, 2020
Published
Sep 14, 2022
Granted
Jun 4, 2025
Protection ends at the latest
Nov 5, 2040
Next annual fee due
Nov 30, 2026
IPC classes
G01N 1/28 (2006.01)
B01L 3/00 (2006.01)
B01L 9/00 (2006.01)
Priority
FR 1912469 06.11.2019
PCT application
PCT/FR2020/052016 06.11.2020
PCT publication
WO2021/089956 14.05.2021
Filing language
French
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Apr 16, 2026

    Change

    Published in Swissreg on 16.04.2026

  2. Dec 1, 2025

    Change

    Published in Swissreg on 01.12.2025

  3. Jun 30, 2025

    Agent entered

    Representative
    Novagraaf International SA, Chemin de l'Echo 3, 1213 Onex

    Published in Swissreg on 30.06.2025

  4. Jun 4, 2025

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 04.06.2025

Parties

Holder

iLsa Diagnostics

8 rue Saint-Hilaire, 95310 Saint-Ouen-l'Aumone, FR

Agent

Novagraaf International SA

Chemin de l'Echo 3, 1213 Onex

Inventor

WALLART, Guillaume

25680 MESANDANS, FR

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.